Literature DB >> 10772949

Intranuclear binding by the HIV-1 regulatory protein VPR is dependent on cytosolic factors.

D A Jans1, P Jans, T Jülich, L J Briggs, C Y Xiao, S C Piller.   

Abstract

The regulatory protein Vpr of the human immunodeficiency virus HIV-1 performs multiple functions during the HIV replicative cycle. It is involved in the transport of the viral preintegration complex into the nucleus, and has the ability to interact with nuclear proteins such as transcription factors and cyclin-dependent kinases. In this study we examine for the first time the kinetics of intranuclear binding and accumulation at the nuclear envelope of fluorescently labelled full-length Vpr in vitro. We show that intranuclear binding is strongly dependent on the presence of cytosolic factors; in the absence of cytosol, Vpr associates predominantly with the nuclear envelope. Specific regulation of the interactions of Vpr with cytosolic factors, as well as with sites at the nuclear envelope and within the nucleus, is thus implicated, but conventional nuclear transport factors such as importin alpha/beta do not appear to be involved. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772949     DOI: 10.1006/bbrc.2000.2559

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Importin-alpha promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr.

Authors:  Masakazu Kamata; Yuko Nitahara-Kasahara; Yoichi Miyamoto; Yoshihiro Yoneda; Yoko Aida
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  Mechanism of microtubule-facilitated "fast track" nuclear import.

Authors:  Daniela Martino Roth; Gregory W Moseley; Colin W Pouton; David A Jans
Journal:  J Biol Chem       Date:  2011-02-21       Impact factor: 5.157

Review 3.  HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.

Authors:  Michael Kogan; Jay Rappaport
Journal:  Retrovirology       Date:  2011-04-13       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.